Catalyst Wire Dossier Catalyst Wire Dossier

Methylphenidate Transdermal System (Daytrana)

methylphenidate transdermal system · Noven Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Methylphenidate Transdermal System (Daytrana), covering 2015-07-09 to 2015-07-09. Get the full timeline:

Most recent: Clinical Trial Update: Safety & Tolerability of MTS in Children Aged 6-12 Diagnosed With ADHD & Previously Treated With Extended-Release Methylphenidate Therapy [Phase 3]

See pricing